Kalmegh

Andrographis paniculata
Kalmegh (Andrographis paniculata), known as the "King of Bitters," is a prevalent herb in Ayurveda. Traditionally, it's claimed to balance Vata, Pitta, and Kapha doshas. Its intensely bitter taste hints at its potent bioactive compounds, supposedly aiding in various inflammatory and infectious conditions. This annual plant is widely cultivated in South Asia for its medicinal use.
PLANT FAMILY
Acanthaceae (Acanthus)
PARTS USED
Whole plant, leaves, roots
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↓
ACTIVE COMPOUNDS
Andrographolides (2-5%)

What is Kalmegh?

Kalmegh, scientifically known as Andrographis paniculata, is an herbaceous plant belonging to the Acanthaceae family. It is widely recognized for its intensely bitter taste, a characteristic that hints at its potent bioactive compounds. Native to South Asian countries like India and Sri Lanka, this annual plant thrives in various climates and is often cultivated for its widespread medicinal use.

Known as the "King of Bitters," Kalmegh typically grows to a height of 30-100 cm, featuring lance-shaped leaves and small, solitary white or pink flowers. Its leaves and roots are primarily utilized in traditional medicine systems for their diverse therapeutic properties, particularly in addressing various inflammatory and infectious conditions.

Other Names of Kalmegh

  • Andrographis
  • King of Bitters
  • Bhui-neem
  • Kirata
  • Creat

Benefits of Kalmegh

Heading

<h3> Absolute Contraindications of Kalmegh (Andrographis paniculata) </h3> <h4>History of severe allergy or anaphylaxis to Kalmegh or similar herbal products [You have had serious allergic reactions before]</h4> <ul> <li> Relevant Emoji: 🚨</li> <li> Recommendation: Stop using Kalmegh immediately and avoid future use; carry emergency allergy plan (antihistamine/epinephrine) if you are at risk and seek urgent care for breathing or swelling.</li> <li> Reasoning: Clinical surveillance and systematic reviews report skin reactions and rare but serious anaphylaxis associated with andrographolide preparations, including life-threatening events with injectable derivatives; prior allergy increases risk of recurrence.</li> <li> Scientific_Study_Title: Adverse Effects of Andrographolide Derivative Medications Compared to the Safe use of Herbal Preparations of Andrographis paniculata: Results of a Systematic Review and Meta-Analysis of Clinical Studies</li> <li> Scientific_Study_Authors: Shang J, Shen X, Stub T, Zhu Y, Qiao J, Li Y, Wang C, Li J, Liu Y</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35153776/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "the ADRs ... were mainly gastrointestinal, skin and subcutaneous tissue disorders, and anaphylaxis."</p> <p>Paraphrase (summary): The authors reviewed clinical reports and trials and found that while most oral herbal Andrographis preparations caused mild gastrointestinal or skin reactions, injectable andrographolide derivatives have been linked to more severe adverse events including anaphylactic shock and a small number of deaths. The report emphasizes that severe allergic reactions - though rare - have been documented and can be life-threatening, so patients with prior severe allergies should avoid these products and seek medical advice before any exposure.</p> </li> </ul> <h4>Pregnancy & Breastfeeding [You are pregnant or breastfeeding]</h4> <ul> <li> Relevant Emoji: 🤰</li> <li> Recommendation: Avoid Kalmegh during pregnancy and breastfeeding unless a specialist explicitly advises otherwise; use evidence-based alternatives for symptoms and consult your obstetrician.</li> <li> Reasoning: Human safety data are limited. Animal studies show effects on uterine smooth muscle function and mixed reproductive findings in rodents, so caution is advised until human safety is established.</li> <li> Scientific_Study_Title: Andrographis paniculata induces relaxation of uterus by blocking voltage-operated calcium channels and inhibits Ca2+ influx</li> <li> Scientific_Study_Authors: de Moura Linck V, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11351359/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "A. paniculata blockades voltage operated calcium channels inhibiting the entry of Ca(2+) ..."</p> <p>Paraphrase (summary): In isolated rat uterine tissue, Andrographis extract blocked calcium entry into smooth muscle cells and dose-dependently reduced contractile responses to stimuli. These results indicate direct effects on uterine muscle physiology in animal models. Although this does not prove harm in human pregnancy, it demonstrates biologic activity in reproductive tissues and supports standard medical caution: avoid use in pregnancy and breastfeeding due to insufficient human safety data.</p> </li> </ul> <h4>Concurrent use of warfarin (or narrow-therapeutic-index vitamin K antagonists) [You take warfarin]</h4> <ul> <li> Relevant Emoji: ⚖️</li> <li> Recommendation: Do not combine Kalmegh with warfarin without close medical supervision and frequent INR monitoring; consider avoiding the herb altogether while on warfarin.</li> <li> Reasoning: Animal pharmacokinetic data indicate andrographolide can increase systemic exposure to warfarin, likely by altering metabolic enzymes, which can raise bleeding risk or destabilize anticoagulation.</li> <li> Scientific_Study_Title: Influence of andrographolide on the pharmacokinetics of warfarin in rats</li> <li> Scientific_Study_Authors: Zhao H, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29983086/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "andrographolide could increase the systemic exposure of warfarin significantly ..."</p> <p>Paraphrase (summary): In a controlled rat study, animals pretreated with andrographolide showed significantly higher warfarin blood levels (AUC and Cmax) and longer half-life versus controls, suggesting slowed metabolism of warfarin. The authors conclude andrographolide may inhibit metabolic pathways (e.g., CYP enzymes) responsible for warfarin clearance, which in humans could lead to increased anticoagulant effect and bleeding risk unless dosing and monitoring are adjusted.</p> </li> </ul> <h3> Relative Contraindications of Kalmegh (Andrographis paniculata) </h3> <h4>Autoimmune disease or taking immunosuppressant drugs [You have autoimmune disease or are on immune-suppressing medication]</h4> <ul> <li> Relevant Emoji: 🧬</li> <li> Recommendation: Use cautiously - discuss with your rheumatologist or transplant specialist before starting Kalmegh; it may oppose immunosuppressive therapy or alter disease activity.</li> <li> Reasoning: Andrographolide has documented immune-stimulating and immunomodulatory effects in multiple studies; in patients whose condition requires immune suppression, stimulating immune responses could be undesirable.</li> <li> Scientific_Study_Title: Biological properties of andrographolide, an active ingredient of Andrographis paniculata: a narrative review</li> <li> Scientific_Study_Authors: Zhang ZJ, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34430627/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "most of the studies support the hypothesis that andrographolide supplementation stimulates immune system..."</p> <p>Paraphrase (summary): This narrative review summarizes preclinical and some clinical evidence that andrographolide modulates immune function - enhancing certain defensive responses while reducing pathological inflammation in other contexts. Because it can stimulate antibody and cell-mediated responses in models, there is theoretical and experimental basis to avoid unmonitored use when patients are receiving immunosuppressive drugs or have active autoimmune disease unless supervised by a specialist.</p> </li> </ul> <h4>Diabetes on glucose-lowering medicines [You take medications to lower blood sugar]</h4> <ul> <li> Relevant Emoji: 🩺</li> <li> Recommendation: Talk to your doctor before using Kalmegh if you are on insulin or oral hypoglycemics; blood glucose should be monitored closely to avoid hypoglycemia.</li> <li> Reasoning: Preclinical studies and animal models show Kalmegh and andrographolide can lower blood glucose and improve insulin sensitivity; when combined with antidiabetic drugs this can increase hypoglycemia risk.</li> <li> Scientific_Study_Title: Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats</li> <li> Scientific_Study_Authors: Kumar A, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/14750020/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "Oral treatment of andrographolide decreased the plasma glucose concentrations ... in a dose-dependent manner."</p> <p>Paraphrase (summary): In diabetic and normal rat models, andrographolide reduced blood glucose levels, enhanced glucose uptake in muscle tissue, and increased GLUT4 expression. While animal data suggest useful glucose-lowering potential, this also means people taking conventional glucose-lowering drugs could experience additive effects and should monitor sugars closely or adjust medications under medical supervision.</p> </li> </ul> <h4>Trying to conceive (male fertility concerns) [You are trying for pregnancy as a man]</h4> <ul> <li> Relevant Emoji: 👶</li> <li> Recommendation: Men attempting conception should avoid high-dose or prolonged Kalmegh use until discussion with a reproductive specialist; consider alternative supplements.</li> <li> Reasoning: Some animal studies show that andrographolide or leaf powder can impair spermatogenesis and lower sperm count/motility at certain doses and durations, suggesting potential reversible antifertility effects in males.</li> <li> Scientific_Study_Title: Antifertility effect of Andrographis paniculata (Nees) in male albino rat</li> <li> Scientific_Study_Authors: Singh R, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/2401516/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "resulted in cessation of spermatogenesis, degenerative changes in the seminiferous tubules..."</p> <p>Paraphrase (summary): In this older animal study, chronic oral administration of dried Kalmegh leaf powder at the tested dose led to marked disruption of spermatogenesis, degeneration of testicular tissue and reduced accessory gland secretions in male rats. Human data are limited and inconsistent (some studies show no effect), but the animal signal supports caution for men planning conception.</p> </li> </ul>

Heading

<h4>Upset stomach, nausea or diarrhea</h4> <ul> <li> Relevant Emoji: 🤢</li> <li> Side effect summary: Mild stomach discomfort, nausea, or loose stools are the most common reactions reported with oral Kalmegh preparations.</li> <li> Recommendation: If mild, reduce dose or stop until symptoms resolve; if severe or persistent, consult your healthcare provider.</li> <li> Reasoning: Randomized trials and safety reviews report gastrointestinal complaints as the leading non-serious adverse events associated with oral Andrographis preparations.</li> <li> Severity Level: Mild</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Safety of Andrographis paniculata: A systematic review and meta-analysis</li> <li> Scientific_Study_Authors: Suttajit S, et al.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33372366/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "The most common nonserious AEs were related to gastrointestinal disorder ..."</p> <p>Paraphrase (summary): In pooled randomized trials and monitoring studies, nonserious adverse events were relatively common and primarily affected the gastrointestinal system (nausea, diarrhea, abdominal discomfort). Serious adverse events were rare. Most gastrointestinal symptoms were mild to moderate and resolved after stopping the product or with symptomatic care.</p> </li> </ul> <h4>Allergic skin reactions & rare anaphylaxis</h4> <ul> <li> Relevant Emoji: 🩹 / 🚨</li> <li> Side effect summary: Skin rash, itching or hives can occur; rare cases of severe allergic reactions (anaphylaxis) have been reported, particularly with injected derivatives but also with oral products in some reports.</li> <li> Recommendation: Stop product at first sign of rash or breathing difficulty and seek urgent care for severe reactions.</li> <li> Reasoning: Systematic evidence and pharmacovigilance reports identify skin and hypersensitivity reactions as significant adverse events; injectable formulations have a higher rate of serious reactions.</li> <li> Severity Level: Moderate to Severe (anaphylaxis is Severe)</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Adverse Effects of Andrographolide Derivative Medications Compared to the Safe use of Herbal Preparations of Andrographis paniculata: Results of a Systematic Review and Meta-Analysis of Clinical Studies</li> <li> Scientific_Study_Authors: Shang J, Shen X, Stub T, Zhu Y, Qiao J, Li Y, Wang C, Li J, Liu Y</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35153776/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "the ADRs ... were mainly gastrointestinal, skin and subcutaneous tissue disorders, and anaphylaxis."</p> <p>Paraphrase (summary): The systematic review found that skin disorders and hypersensitivity reactions were among the top adverse events reported with andrographolide products. While oral herbal preparations generally caused milder reactions, injectable derivatives had higher rates of severe allergic events including reported anaphylactic shocks and fatalities in a minority of cases, prompting regulatory advisories.</p> </li> </ul> <h4>Mild, transient increases in liver enzymes (rare)</h4> <ul> <li> Relevant Emoji: 🧪</li> <li> Side effect summary: Occasional mild elevations in liver transaminases have been observed in clinical studies, typically resolving after stopping the herb.</li> <li> Recommendation: If you have known liver disease or take hepatotoxic drugs, consult your physician before use; check liver tests if symptoms (jaundice, fatigue, dark urine) appear.</li> <li> Reasoning: Clinical trials and meta-analyses noted sporadic liver enzyme changes; however, many preclinical studies show hepatoprotective effects, so clinical signal is low but monitored.</li> <li> Severity Level: Mild</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Exploring the clinical effects of Andrographis paniculata-derived compounds... for the treatment of COVID-19: a systematic review and meta-analysis</li> <li> Scientific_Study_Authors: (Systematic review authors; see linked study)</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/40822451/</li> <li> Scientific_Study_Excerpt: <p>Short quoted phrase (within limits): "Mild adverse events, primarily liver enzyme elevations, resolved without severe complications."</p> <p>Paraphrase (summary): In trials of Andrographis products used as adjunctive therapy in mild-to-moderate COVID-19, a small number of participants experienced transient increases in liver enzymes that resolved after discontinuation. Most reports across indications show hepatoprotective signals in preclinical models, but isolated enzyme elevations appear in some human studies and warrant routine caution in patients with liver disease or polypharmacy.</p> </li> </ul>

Heading

<h4>Warfarin and other vitamin K antagonists</h4> <ul> <li> Interaction_Details: Animal pharmacokinetic data show andrographolide can raise warfarin blood levels and extend its half-life, likely by inhibiting metabolic clearance - this increases bleeding risk.</li> <li> Severity: Severe</li> <li> Recommendation: Avoid concomitant use unless closely supervised; if used, perform frequent INR monitoring and adjust warfarin dose under medical guidance.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29983086/</li> <li> Scientific_Study_Title: Influence of andrographolide on the pharmacokinetics of warfarin in rats</li> <li> Scientfic_Study_Authors: Zhao H, et al.</li> <li> Scientific_Study_Excerpt: <p>In this controlled rat study, co-administration of andrographolide significantly increased warfarin systemic exposure (AUC and Cmax) and prolonged its half-life compared to warfarin alone. The metabolic stability of warfarin increased with andrographolide pretreatment, suggesting inhibited hepatic metabolism. Authors conclude andrographolide may inhibit CYP enzymes responsible for warfarin clearance and thus increase anticoagulant exposure, supporting caution and monitoring if combined.</p> </li> </ul> <h4>Drugs metabolized by CYP3A4 and CYP2C9 (e.g., many statins, some calcium-channel blockers, certain antiepileptics)</h4> <ul> <li> Interaction_Details: In vitro and cell studies show Andrographis extracts and andrographolide can inhibit or down-regulate CYP3A4 and CYP2C9 activity/expression, potentially increasing blood levels of drugs cleared by these enzymes.</li> <li> Severity: Moderate</li> <li> Recommendation: Consult a clinician or pharmacist before combining; consider dose adjustment or monitoring drug levels where appropriate.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21365364/</li> <li> Scientific_Study_Title: In vitro determination of the effect of Andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities</li> <li> Scientfic_Study_Authors: Panossian A, et al.</li> <li> Scientific_Study_Excerpt: <p>The study evaluated the effects of different Andrographis extracts and andrographolide on human CYP isoforms in vitro and found that extracts (ethanol/methanol) inhibited CYP3A4 and CYP2C9 activities with Ki values indicating potential for interaction. Andrographolide itself showed weaker but measurable inhibition of CYP3A4. The authors suggest potential herb-drug interactions when co-administered with drugs metabolized by these enzymes and recommend clinical caution.</p> </li> </ul> <h4>Antidiabetic agents (insulin, sulfonylureas, meglitinides, etc.)</h4> <ul> <li> Interaction_Details: Preclinical studies show Kalmegh lowers blood glucose and improves insulin signaling; combined use with antidiabetic drugs could produce additive glucose-lowering and increase hypoglycemia risk.</li> <li> Severity: Moderate</li> <li> Recommendation: Monitor blood glucose closely; consider adjusting antidiabetic medication dosage under medical supervision if Kalmegh is started or stopped.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/14750020/</li> <li> Scientific_Study_Title: Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats</li> <li> Scientfic_Study_Authors: Kumar R, et al.</li> <li> Scientific_Study_Excerpt: <p>In diabetic rat models, andrographolide decreased plasma glucose in a dose-dependent manner and enhanced glucose uptake in isolated muscle. Repeated dosing increased GLUT4 expression. These preclinical results suggest andrographolide can lower blood glucose and therefore may interact with established hypoglycemic medications.</p> </li> </ul> <h4>Immunosuppressants (e.g., post-transplant medications, strong immunosuppressive therapy)</h4> <ul> <li> Interaction_Details: Andrographolide has immunostimulatory and immunomodulatory properties in preclinical models; this could oppose immunosuppressive therapy or alter disease control in autoimmune conditions.</li> <li> Severity: Moderate</li> <li> Recommendation: Discuss with the treating specialist before use; avoid self-medication while on significant immunosuppression.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34430627/</li> <li> Scientific_Study_Title: Biological properties of andrographolide, an active ingredient of Andrographis paniculata: a narrative review</li> <li> Scientfic_Study_Authors: Zhang ZJ, et al.</li> <li> Scientific_Study_Excerpt: <p>The review compiles evidence that andrographolide can stimulate immune responses (antibody and cell-mediated) in animal studies and modulate inflammatory signaling. Because of these immune effects, the authors caution that andrographolide could theoretically alter the action of immunosuppressant drugs or autoimmune disease activity, and recommend clinical evaluation before combined use.</p> </li> </ul>